Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,982
archived clinical trials in
Endocrine

20120231: Single-arm Extension Study of AMG 416 in the Treatment of SHPT in CKD Subjects on HD
A Multicenter Single-arm Extension Study to Describe the Long-term Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis
Status: Enrolling
Updated:  12/19/2015
Clinical Research Facility
mi
from
Lubbock, TX
20120231: Single-arm Extension Study of AMG 416 in the Treatment of SHPT in CKD Subjects on HD
A Multicenter Single-arm Extension Study to Describe the Long-term Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis
Status: Enrolling
Updated: 12/19/2015
Clinical Research Facility
mi
from
Lubbock, TX
Click here to add this to my saved trials
20120231: Single-arm Extension Study of AMG 416 in the Treatment of SHPT in CKD Subjects on HD
A Multicenter Single-arm Extension Study to Describe the Long-term Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis
Status: Enrolling
Updated:  12/19/2015
Clinical Research Facility
mi
from
Mansfield, TX
20120231: Single-arm Extension Study of AMG 416 in the Treatment of SHPT in CKD Subjects on HD
A Multicenter Single-arm Extension Study to Describe the Long-term Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis
Status: Enrolling
Updated: 12/19/2015
Clinical Research Facility
mi
from
Mansfield, TX
Click here to add this to my saved trials
20120231: Single-arm Extension Study of AMG 416 in the Treatment of SHPT in CKD Subjects on HD
A Multicenter Single-arm Extension Study to Describe the Long-term Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis
Status: Enrolling
Updated:  12/19/2015
Clinical Research Facility
mi
from
San Antonio, TX
20120231: Single-arm Extension Study of AMG 416 in the Treatment of SHPT in CKD Subjects on HD
A Multicenter Single-arm Extension Study to Describe the Long-term Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis
Status: Enrolling
Updated: 12/19/2015
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
20120231: Single-arm Extension Study of AMG 416 in the Treatment of SHPT in CKD Subjects on HD
A Multicenter Single-arm Extension Study to Describe the Long-term Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis
Status: Enrolling
Updated:  12/19/2015
Clinical Research Facility
mi
from
San Antonio, TX
20120231: Single-arm Extension Study of AMG 416 in the Treatment of SHPT in CKD Subjects on HD
A Multicenter Single-arm Extension Study to Describe the Long-term Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis
Status: Enrolling
Updated: 12/19/2015
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
20120231: Single-arm Extension Study of AMG 416 in the Treatment of SHPT in CKD Subjects on HD
A Multicenter Single-arm Extension Study to Describe the Long-term Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis
Status: Enrolling
Updated:  12/19/2015
Clinical Research Facility
mi
from
San Antonio, TX
20120231: Single-arm Extension Study of AMG 416 in the Treatment of SHPT in CKD Subjects on HD
A Multicenter Single-arm Extension Study to Describe the Long-term Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis
Status: Enrolling
Updated: 12/19/2015
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
20120231: Single-arm Extension Study of AMG 416 in the Treatment of SHPT in CKD Subjects on HD
A Multicenter Single-arm Extension Study to Describe the Long-term Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis
Status: Enrolling
Updated:  12/19/2015
Clinical Research Facility
mi
from
Alexandria, VA
20120231: Single-arm Extension Study of AMG 416 in the Treatment of SHPT in CKD Subjects on HD
A Multicenter Single-arm Extension Study to Describe the Long-term Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis
Status: Enrolling
Updated: 12/19/2015
Clinical Research Facility
mi
from
Alexandria, VA
Click here to add this to my saved trials
20120231: Single-arm Extension Study of AMG 416 in the Treatment of SHPT in CKD Subjects on HD
A Multicenter Single-arm Extension Study to Describe the Long-term Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis
Status: Enrolling
Updated:  12/19/2015
Clinical Research Facility
mi
from
Alexandria, VA
20120231: Single-arm Extension Study of AMG 416 in the Treatment of SHPT in CKD Subjects on HD
A Multicenter Single-arm Extension Study to Describe the Long-term Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis
Status: Enrolling
Updated: 12/19/2015
Clinical Research Facility
mi
from
Alexandria, VA
Click here to add this to my saved trials
20120231: Single-arm Extension Study of AMG 416 in the Treatment of SHPT in CKD Subjects on HD
A Multicenter Single-arm Extension Study to Describe the Long-term Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis
Status: Enrolling
Updated:  12/19/2015
Clinical Research Facility
mi
from
Fairfax, VA
20120231: Single-arm Extension Study of AMG 416 in the Treatment of SHPT in CKD Subjects on HD
A Multicenter Single-arm Extension Study to Describe the Long-term Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis
Status: Enrolling
Updated: 12/19/2015
Clinical Research Facility
mi
from
Fairfax, VA
Click here to add this to my saved trials
20120231: Single-arm Extension Study of AMG 416 in the Treatment of SHPT in CKD Subjects on HD
A Multicenter Single-arm Extension Study to Describe the Long-term Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis
Status: Enrolling
Updated:  12/19/2015
Clinical Research Facility
mi
from
Hampton, VA
20120231: Single-arm Extension Study of AMG 416 in the Treatment of SHPT in CKD Subjects on HD
A Multicenter Single-arm Extension Study to Describe the Long-term Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis
Status: Enrolling
Updated: 12/19/2015
Clinical Research Facility
mi
from
Hampton, VA
Click here to add this to my saved trials
20120231: Single-arm Extension Study of AMG 416 in the Treatment of SHPT in CKD Subjects on HD
A Multicenter Single-arm Extension Study to Describe the Long-term Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis
Status: Enrolling
Updated:  12/19/2015
Clinical Research Facility
mi
from
Mechanicsville, VA
20120231: Single-arm Extension Study of AMG 416 in the Treatment of SHPT in CKD Subjects on HD
A Multicenter Single-arm Extension Study to Describe the Long-term Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis
Status: Enrolling
Updated: 12/19/2015
Clinical Research Facility
mi
from
Mechanicsville, VA
Click here to add this to my saved trials
20120231: Single-arm Extension Study of AMG 416 in the Treatment of SHPT in CKD Subjects on HD
A Multicenter Single-arm Extension Study to Describe the Long-term Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis
Status: Enrolling
Updated:  12/19/2015
Clinical Research Facility
mi
from
Norfolk, VA
20120231: Single-arm Extension Study of AMG 416 in the Treatment of SHPT in CKD Subjects on HD
A Multicenter Single-arm Extension Study to Describe the Long-term Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis
Status: Enrolling
Updated: 12/19/2015
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
20120231: Single-arm Extension Study of AMG 416 in the Treatment of SHPT in CKD Subjects on HD
A Multicenter Single-arm Extension Study to Describe the Long-term Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis
Status: Enrolling
Updated:  12/19/2015
Clinical Research Facility
mi
from
Bluefield, WV
20120231: Single-arm Extension Study of AMG 416 in the Treatment of SHPT in CKD Subjects on HD
A Multicenter Single-arm Extension Study to Describe the Long-term Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis
Status: Enrolling
Updated: 12/19/2015
Clinical Research Facility
mi
from
Bluefield, WV
Click here to add this to my saved trials
20120231: Single-arm Extension Study of AMG 416 in the Treatment of SHPT in CKD Subjects on HD
A Multicenter Single-arm Extension Study to Describe the Long-term Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis
Status: Enrolling
Updated:  12/19/2015
Clinical Research Facility
mi
from
Cudahy, CA
20120231: Single-arm Extension Study of AMG 416 in the Treatment of SHPT in CKD Subjects on HD
A Multicenter Single-arm Extension Study to Describe the Long-term Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis
Status: Enrolling
Updated: 12/19/2015
Clinical Research Facility
mi
from
Cudahy, CA
Click here to add this to my saved trials
20120231: Single-arm Extension Study of AMG 416 in the Treatment of SHPT in CKD Subjects on HD
A Multicenter Single-arm Extension Study to Describe the Long-term Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis
Status: Enrolling
Updated:  12/19/2015
Clinical Research Facility
mi
from
Bethlehem, PA
20120231: Single-arm Extension Study of AMG 416 in the Treatment of SHPT in CKD Subjects on HD
A Multicenter Single-arm Extension Study to Describe the Long-term Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis
Status: Enrolling
Updated: 12/19/2015
Clinical Research Facility
mi
from
Bethlehem, PA
Click here to add this to my saved trials
20120231: Single-arm Extension Study of AMG 416 in the Treatment of SHPT in CKD Subjects on HD
A Multicenter Single-arm Extension Study to Describe the Long-term Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis
Status: Enrolling
Updated:  12/19/2015
mi
from
Liverpool,
20120231: Single-arm Extension Study of AMG 416 in the Treatment of SHPT in CKD Subjects on HD
A Multicenter Single-arm Extension Study to Describe the Long-term Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis
Status: Enrolling
Updated: 12/19/2015
mi
from
Liverpool,
Click here to add this to my saved trials
Inflammation and the Metabolic Syndrome in Humans
Inflammation and the Metabolic Syndrome in Humans
Status: Enrolling
Updated:  12/21/2015
Clinical and Translational Research Center, Hospital of University of Pennsylvania
mi
from
Philadelphia, PA
Inflammation and the Metabolic Syndrome in Humans
Inflammation and the Metabolic Syndrome in Humans
Status: Enrolling
Updated: 12/21/2015
Clinical and Translational Research Center, Hospital of University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Leptin for Abnormal Lipid Kinetics in HIV Lipodystrophy Syndrome
The Effect of Leptin Therapy on Abnormal Lipid Kinetics in Subjects With HIV Lipodystrophy Syndrome
Status: Enrolling
Updated:  12/21/2015
Baylor College of Medicine
mi
from
Houston, TX
Leptin for Abnormal Lipid Kinetics in HIV Lipodystrophy Syndrome
The Effect of Leptin Therapy on Abnormal Lipid Kinetics in Subjects With HIV Lipodystrophy Syndrome
Status: Enrolling
Updated: 12/21/2015
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Electromagnetic Treatment For Bone Loss After Forearm Fracture
Feasibility and Dosing Study of Bone Density Changes With and Without PEMF Following Immobilization of the Forearm
Status: Enrolling
Updated:  12/22/2015
Institute for Human Performance/Upstate Medical University
mi
from
Syracuse, NY
Electromagnetic Treatment For Bone Loss After Forearm Fracture
Feasibility and Dosing Study of Bone Density Changes With and Without PEMF Following Immobilization of the Forearm
Status: Enrolling
Updated: 12/22/2015
Institute for Human Performance/Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated:  12/24/2015
Clinical Research Facility
mi
from
Aurora, CO
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated: 12/24/2015
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated:  12/24/2015
Clinical Research Facility
mi
from
Boston, MA
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated: 12/24/2015
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated:  12/24/2015
Clinical Research Facility
mi
from
Cleveland, OH
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated: 12/24/2015
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated:  12/24/2015
Clinical Research Facility
mi
from
Portland, OR
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated: 12/24/2015
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated:  12/24/2015
Clinical Research Facility
mi
from
Philadelphia, PA
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated: 12/24/2015
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated:  12/24/2015
Clinical Research Facility
mi
from
Milwaukee, WI
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated: 12/24/2015
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated:  12/24/2015
Clinical Research Facility
mi
from
La Jolla, CA
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated: 12/24/2015
Clinical Research Facility
mi
from
La Jolla, CA
Click here to add this to my saved trials
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated:  12/24/2015
Clinical Research Facility
mi
from
Los Angeles, CA
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated: 12/24/2015
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated:  12/24/2015
Clinical Research Facility
mi
from
Palo Alto, CA
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated: 12/24/2015
Clinical Research Facility
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated:  12/24/2015
Clinical Research Facility
mi
from
San Francisco, CA
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated: 12/24/2015
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated:  12/24/2015
Clinical Research Facility
mi
from
Washington DC,
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated: 12/24/2015
Clinical Research Facility
mi
from
Washington DC,
Click here to add this to my saved trials
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated:  12/24/2015
Clinical Research Facility
mi
from
Gainesville, FL
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated: 12/24/2015
Clinical Research Facility
mi
from
Gainesville, FL
Click here to add this to my saved trials
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated:  12/24/2015
Clinical Research Facility
mi
from
Tampa, FL
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated: 12/24/2015
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated:  12/24/2015
Clinical Research Facility
mi
from
Atlanta, GA
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated: 12/24/2015
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated:  12/24/2015
Clinical Research Facility
mi
from
Chicago, IL
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated: 12/24/2015
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated:  12/24/2015
Clinical Research Facility
mi
from
Indianapolis, IN
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated: 12/24/2015
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated:  12/24/2015
Clinical Research Facility
mi
from
Minneapolis, MN
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated: 12/24/2015
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated:  12/24/2015
Clinical Research Facility
mi
from
Albany, NY
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated: 12/24/2015
Clinical Research Facility
mi
from
Albany, NY
Click here to add this to my saved trials
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated:  12/24/2015
Clinical Research Facility
mi
from
Buffalo, NY
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated: 12/24/2015
Clinical Research Facility
mi
from
Buffalo, NY
Click here to add this to my saved trials
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated:  12/24/2015
Clinical Research Facility
mi
from
Rochester, NY
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated: 12/24/2015
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated:  12/24/2015
Clinical Research Facility
mi
from
Chapel Hill, NC
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated: 12/24/2015
Clinical Research Facility
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated:  12/24/2015
Clinical Research Facility
mi
from
Hershey, PA
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated: 12/24/2015
Clinical Research Facility
mi
from
Hershey, PA
Click here to add this to my saved trials
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated:  12/24/2015
Clinical Research Facility
mi
from
Pittsburgh, PA
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated: 12/24/2015
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated:  12/24/2015
Clinical Research Facility
mi
from
Nashville, TN
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated: 12/24/2015
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated:  12/24/2015
Clinical Research Facility
mi
from
Dallas, TX
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated: 12/24/2015
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated:  12/24/2015
Clinical Research Facility
mi
from
Madison, WI
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated: 12/24/2015
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated:  12/24/2015
mi
from
Calgary,
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Status: Enrolling
Updated: 12/24/2015
mi
from
Calgary,
Click here to add this to my saved trials
Weight Loss Study-Mechanism Underlying the Improvement of Insulin Resistance in Response to Weight Loss
Weight Loss Study-Mechanism Underlying the Improvement of Insulin Resistance in Response to Weight Loss
Status: Enrolling
Updated:  12/24/2015
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Weight Loss Study-Mechanism Underlying the Improvement of Insulin Resistance in Response to Weight Loss
Weight Loss Study-Mechanism Underlying the Improvement of Insulin Resistance in Response to Weight Loss
Status: Enrolling
Updated: 12/24/2015
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Trial of Rituximab for Graves' Ophthalmopathy
Phase 2/3 Study of Rituximab for Graves' Ophthalmopathy
Status: Enrolling
Updated:  12/30/2015
The Mayo Clinic
mi
from
Rochester, MN
Trial of Rituximab for Graves' Ophthalmopathy
Phase 2/3 Study of Rituximab for Graves' Ophthalmopathy
Status: Enrolling
Updated: 12/30/2015
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
The Effects of Altering Physical Activity on Cardiometabolic Health
The Effects of Altering Physical Activity on Endothelial Function, Glycemic Control, and the Blood Flow Response to an Oral Glucose Tolerance Test.
Status: Enrolling
Updated:  1/4/2016
University of Missouri
mi
from
Columbia, MO
The Effects of Altering Physical Activity on Cardiometabolic Health
The Effects of Altering Physical Activity on Endothelial Function, Glycemic Control, and the Blood Flow Response to an Oral Glucose Tolerance Test.
Status: Enrolling
Updated: 1/4/2016
University of Missouri
mi
from
Columbia, MO
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of G-Pen(TM) (Glucagon Injection) to Treat Severe Hypoglycemia
A RANDOMIZED, PHASE 2, DOUBLE-BLIND, 3-WAY CROSSOVER STUDY WITH G-PEN™ (GLUCAGON INJECTION) TO EVALUATE SAFETY, TOLERABILITY AND COMPARATIVE PHARMACOKINETICS AND PHARMACODYNAMICS TO LILLY GLUCAGON™ (GLUCAGON FOR INJECTION [rDNA ORIGIN]) IN HEALTHY VOLUNTEERS
Status: Enrolling
Updated:  1/4/2016
Texas Diabetes Institute, University Health System
mi
from
San Antonio, TX
Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of G-Pen(TM) (Glucagon Injection) to Treat Severe Hypoglycemia
A RANDOMIZED, PHASE 2, DOUBLE-BLIND, 3-WAY CROSSOVER STUDY WITH G-PEN™ (GLUCAGON INJECTION) TO EVALUATE SAFETY, TOLERABILITY AND COMPARATIVE PHARMACOKINETICS AND PHARMACODYNAMICS TO LILLY GLUCAGON™ (GLUCAGON FOR INJECTION [rDNA ORIGIN]) IN HEALTHY VOLUNTEERS
Status: Enrolling
Updated: 1/4/2016
Texas Diabetes Institute, University Health System
mi
from
San Antonio, TX
Click here to add this to my saved trials
Exercise, Statins, and the Metabolic Syndrome
Exercise, Statins, and the Metabolic Syndrome
Status: Enrolling
Updated:  1/4/2016
University of Missouri
mi
from
Columbia, MO
Exercise, Statins, and the Metabolic Syndrome
Exercise, Statins, and the Metabolic Syndrome
Status: Enrolling
Updated: 1/4/2016
University of Missouri
mi
from
Columbia, MO
Click here to add this to my saved trials